WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1994015574) COMPOSITIONS FOR TREATMENT OF THE HAIR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1994/015574    International Application No.:    PCT/GB1994/000021
Publication Date: 21.07.1994 International Filing Date: 06.01.1994
Chapter 2 Demand Filed:    01.08.1994    
IPC:
A61K 8/31 (2006.01), A61K 8/362 (2006.01), A61K 8/365 (2006.01), A61K 8/92 (2006.01), A61K 8/97 (2006.01), A61Q 5/00 (2006.01), A61Q 7/00 (2006.01), A61Q 19/00 (2006.01)
Applicants: BOURAS, Elias [GB/GB]; (GB)
Inventors: BOURAS, Elias; (GB)
Agent: STEBBING, Peter, John, Hunter; Ablett & Stebbing, 45 Lancaster Mews, Lancaster Gate, London W2 3QQ (GB)
Priority Data:
9300411.7 11.01.1993 GB
9308572.8 26.04.1993 GB
9311437.9 03.06.1993 GB
9320329.7 01.10.1993 GB
Title (EN) COMPOSITIONS FOR TREATMENT OF THE HAIR
(FR) COMPOSITION DE TRAITEMENT DES CHEVEUX
Abstract: front page image
(EN)The invention provides a composition for the treatment for the hair, scalp and skin to improve condition and to assist in hair regrowth which comprises a pharmaceutically acceptable oxalate of a group Ia or IIa or ammonium oxalate metal disposed in a pharmaceutically acceptable carrier or diluent therefor. Preferably, the group IIa metal is calcium and the pharmaceutically acceptable carrier or diluent is an ointment.
(FR)Composition de traitement destinée aux cheveux, au cuir chevelu et à la peau permettant d'améliorer l'état général et de stimuler la réponse des cheveux. Cette composition comprend un oxalate pharmaceutiquement acceptable d'un métal du groupe Ia ou IIa ou d'un métal oxalate ammonium placé dans un support ou un diluant approprié pharmaceutiquement acceptable. De préférence le métal du groupe IIa est du calcium et le support ou le diluant pharmaceutiquement acceptable est un onguent.
Designated States: AT, AU, BB, BG, BR, BY, CA, CH, CZ, DE, DK, ES, FI, GB, HU, JP, KP, KR, KZ, LK, LU, MG, MN, MW, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SK, UA, US, VN.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)